Evidence map›Paper›PMID 31391534›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2020

Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA.

Francesca Romana Grati, Jose Ferreira, Peter Benn, Claudia Izzi, Federica Verdi, Elena Vercellotti, Cristina Dalpiaz, Patrizia D'Ajello, Elisa Filippi, Nicola Volpe and 10 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
22.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 104 citations in OpenAlex.

  1. Pooled it
  2. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Francesca Romana GratiUnit of Research and Development, Cytogenetics and Medical Genetics TOMA, Advanced Biomedical Assays, Impact Lab Group, Busto Arsizio, Varese, Italy. fgrati@tomalab.com.ORCID http://orcid.org/0000-0002-3836-5190
Jose FerreiraFaculty of Medicine, Eduardo Mondlane University, Maputo, Mozambique.ORCID http://orcid.org/0000-0003-0517-8230
Peter BennDepartment of Genetics and Genome Sciences, University of Connecticut Health Center, Farmington, CT, USA.
Claudia IzziUO Diagnosi Prenatale, Azienda Ospedaliera Spedali Civili, Brescia, Italy.
Federica VerdiOstetricia e Ginecologia, Ospedale di Bolzano, Bolzano, Italy.
Elena VercellottiUniversità del Piemonte Orientale, Novara, Italy.
Cristina DalpiazUO Ostetricia e Ginecologia, Clinica Pederzoli, Peschiera del Garda, Italy.
Patrizia D'AjelloUniversità del Piemonte Orientale, Novara, Italy.
Elisa FilippiUOC Ginecologia e Ostetricia, Osp. Cà Foncello Treviso, Treviso, Italy.
Nicola VolpeDepartment of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Parma, Italy.
Francesca MalvestitiUnit of Research and Development, Cytogenetics and Medical Genetics TOMA, Advanced Biomedical Assays, Impact Lab Group, Busto Arsizio, Varese, Italy.
Federico MaggiUnit of Research and Development, Cytogenetics and Medical Genetics TOMA, Advanced Biomedical Assays, Impact Lab Group, Busto Arsizio, Varese, Italy.
Giuseppe SimoniUnit of Research and Development, Cytogenetics and Medical Genetics TOMA, Advanced Biomedical Assays, Impact Lab Group, Busto Arsizio, Varese, Italy.
Tiziana FruscaDepartment of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Parma, Italy.
Gaetana CirelliOstetricia e Ginecologia, Ospedale Santorso AULSS7 Pedemontana (VI), Santorso, Italy.
Gabriella BracalenteUOC Ginecologia e Ostetricia, Osp. Cà Foncello Treviso, Treviso, Italy.
Antonino Lo ReUO Ostetricia e Ginecologia, Clinica Pederzoli, Peschiera del Garda, Italy.
Daniela SuricoUniversità del Piemonte Orientale, Novara, Italy.
Tullio GhiDepartment of Medicine and Surgery, Unit of Surgical Sciences, Obstetrics and Gynecology, University of Parma, Parma, Italy.ORCID http://orcid.org/0000-0003-1823-1096
Federico PrefumoUO Diagnosi Prenatale, Azienda Ospedaliera Spedali Civili, Brescia, Italy.ORCID http://orcid.org/0000-0001-7793-714X
Università degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Parma · ITAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · ITCa' Foncello Hospital · ITCasa di Cura Villa Garda · ITGenomed (Poland) · PLOspedale di Bolzano · ITUConn Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo assess the association between confined placental mosaicism (CPM) and adverse pregnancy outcome.

methodsA retrospective cohort study was carried out evaluating the outcome of pregnancies with and without CPM involving a rare autosomal trisomy (RAT) or tetraploidy. Birthweight, gestational age at delivery, fetal growth restriction (FGR), Apgar score, neonatal intensive care admission, preterm delivery, and hypertensive disorders of pregnancy were considered.

resultsOverall 181 pregnancies with CPM and 757 controls were recruited. Outcome information was available for 69% of cases (n = 124) and 62% of controls (n = 468). CPM involving trisomy 16 (T16) was associated with increased incidence of birthweight <3rd centile (P = 0.007, odds ratio [OR] = 11.2, 95% confidence interval [CI] = 2.7-47.1) and preterm delivery (P = 0.029, OR = 10.2, 95% CI = 1.9-54.7). For the other RATs, an association with prenatally diagnosed FGR was not supported by birthweight data and there were no other strong associations with adverse outcomes.

conclusionExcluding T16, the incidence of adverse pregnancy outcomes for pregnancies carrying a CPM is low. RATs can also be identified through genome-wide cell-free DNA screening. Because most of these will be attributable to CPMs, we conclude that this screening is of minimal benefit.

Indexed as

Cell-Free Nucleic AcidsChromosomes, Human, Pair 16Cohort StudiesFemaleFetal Growth RetardationFetusGestational AgeHumansInfant, NewbornInfant, Small for Gestational AgeMosaicismNoninvasive Prenatal TestingPlacentaPlacentationPregnancyPregnancy OutcomeCell-Free Nucleic Acidsconfined placental mosaicismgenome-wide cfDNA testlow birthweightpregnancy complicationsrare autosomal trisomies

Identifiers

PMID31391534
OpenAlexW2966417962

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.